Detalhe da pesquisa
1.
Intravenous Fluid Bolus Volume and Resolution of Acute Kidney Injury in Children With Diabetic Ketoacidosis.
Pediatr Emerg Care
; 39(2): 67-73, 2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719386
2.
Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonist.
Int J Obes (Lond)
; 46(3): 623-629, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34975146
3.
MRI measures of hypothalamic injury are associated with glucagon-like peptide-1 receptor agonist treatment response in people with hypothalamic obesity.
Diabetes Obes Metab
; 23(7): 1532-1541, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651438
4.
A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity.
Diabetes Obes Metab
; 23(2): 363-373, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33026160
5.
Resuscitation With Ringer's Lactate Compared With Normal Saline for Pediatric Diabetic Ketoacidosis.
Pediatr Emerg Care
; 37(5): e236-e242, 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30020245
6.
A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity.
Diabetes Obes Metab
; 19(8): 1165-1170, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28261955
7.
Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.
Diabetes Obes Metab
; 19(12): 1751-1761, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28556449
8.
Predominance of DR3 in Somali children with type 1 diabetes in the twin cities, Minnesota.
Pediatr Diabetes
; 18(2): 136-142, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26854192
9.
Understanding Cultural Beliefs in Families of Somali Children with Diabetes in the Twin Cities, Minnesota.
J Community Health
; 40(4): 827-33, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25925720
10.
Multicentre, retrospective cohort study protocol to identify racial and ethnic differences in acute kidney injuries in children and adolescents with diabetic ketoacidosis.
BMJ Open
; 14(6): e086261, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38839382
11.
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial.
Lancet Diabetes Endocrinol
; 12(6): 380-389, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697184
12.
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study.
Obesity (Silver Spring)
; 32(2): 252-261, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919617
13.
Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial.
EClinicalMedicine
; 65: 102258, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823031
14.
Association of Neighborhood Resources and Race and Ethnicity With Readmissions for Diabetic Ketoacidosis at US Children's Hospitals.
JAMA Netw Open
; 5(5): e2210456, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511179
15.
Genetic conditions of short stature: A review of three classic examples.
Front Endocrinol (Lausanne)
; 13: 1011960, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36339399
16.
Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study.
Int J Pediatr Endocrinol
; 2020(1): 20, 2020 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33292530
17.
A Quality Improvement Initiative to Reduce Hospitalizations for Low-risk Diabetic Ketoacidosis.
Pediatrics
; 145(3)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32054821
18.
Hypothalamic Obesity: Prologue and Promise.
Horm Res Paediatr
; 91(2): 128-136, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30884480
19.
IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation.
N Engl J Med
; 349(23): 2211-22, 2003 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-14657428
20.
The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial.
JAMA Pediatr
; 167(4): 355-60, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23380890